Journal of Clinical Oncology | ASCO Publications
WEBJournal of Clinical Oncology (JCO) is a high-impact, peer-reviewed medical journal that publishes significant clinical oncology research along with editorials, reviews, and other works that relate to the care of patients with cancer.
Management of Immune-Related Adverse Events in Patients …
WEBTo increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitor (ICPi) therapy.
Evidence-Based Management of Oral Mucositis - ASCO Publications
WEBFeb 3, 2020 · The morbidity of oral mucositis includes pain, nutritional compromise, and infection risk, which potentially result in breaks or dose reductions in cancer therapy. Historically, management was focused mainly on pain control and nutritional support. However, evidence-based clinical practice guidelines for …
Survival in Patients With Brain Metastases: Summary Report on the ...
WEBSep 15, 2020 · PURPOSEConventional wisdom has rendered patients with brain metastases ineligible for clinical trials for fear that poor survival could mask the benefit of otherwise promising treatments. Our group previously published the …
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted …
WEBJan 28, 2021 · PURPOSETo develop guideline recommendations concerning optimal neoadjuvant therapy for breast cancer.METHODSASCO convened an Expert Panel to conduct a systematic review of the literature on neoadjuvant therapy for breast cancer and provide recommended ...
Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on ...
WEBJan 14, 2021 · This overview aims to create an understanding of the nutritional issues concerning patients with cancer and provide evidence-based practical guidance to healthcare professionals (physicians, nurses, and dietitians), caregivers, and all others involved in the care of patients with cancer. The focus of this paper is therefore on providing a simple guide for daily clinical practice. The ...
Current and Future Management of HER2-Positive Metastatic …
WEBJun 2, 2021 · The combination of trastuzumab and pertuzumab and a single-agent chemotherapeutic should be the standard first-line treatment for most patients with HER2-positive advanced breast cancer. Pertuzumab is a monoclonal antibody binding to the HER2 extracellular domain II, which prevents dimerization of HER2 with other HER receptors and together with trastuzumab allow a more comprehensive signaling ...
Recurrence, metastasis, and survival after radical prostatectomy in …
WEBJun 2, 2022 · 5090Background: Accurate survival estimates after prostatectomy are critical for patient counseling, treatment decisions, and trial design. Prior prostate cancer natural history studies may not reflect contemporary outcomes and often lack key endpoints (...
Advances in Breast Cancer Radiotherapy: Implications for Current …
WEBOct 15, 2021 · Radiation therapy (RT) is an essential component in the management of breast cancer. Following breast-conserving surgery (BCS), adjuvant RT is the standard of care for most patients. Traditionally, RT was delivered with standard whole breast irradiation (...
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
WEBPatients with symptomatic brain metastases should be offered local therapy (radiosurgery or radiation therapy and/or surgery) as recommended in this guideline regardless of the systemic therapy used for the systemic disease (Type: evidence-based; Evidence quality: high; Strength of recommendation: strong).